跳至主要内容
临床试验/IRCT20180722040556N7
IRCT20180722040556N7招募中3 期

Omega 3 in the management of menopausal complication due to hormonal therapy in breast cancer patients

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Adult women suffering from hormone-positive breast cancer with grade I to III who are receiving Selective estrogen receptor modulators (SERM) or Aromatase inhibitors (AIs) family drug.
  • Patients who are complaining from hot flash ( at least 4 times in a previous month)
  • Patients who have compliance and ability to take omega 3 orally

排除标准

  • Patients who are in metastatic stage
  • Patients who have a history of other malignancies except for breast cancer
  • Patients who are receiving antipsychotic, anti-depression, anti-anxiolytic, sedative or hypnotic or anti-epileptic drugs
  • Patients with a history of hypersensitivity reaction to omega 3

研究者

相似试验

Omega 3 in the management of breast cancer patients | 临床试验